MG
IRON icon

Michael Gelband’s Disc Medicine IRON Stock Holding History

Michael Gelband’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.78M Buy
+51,623
New +$3.55M 0.02% 592
2026
Q1 		– Sell
-58,211
Closed -$4.62M – 1817
2025
Q4 		$4.62M Buy
+58,211
New +$4.92M 0.04% 494
2025
Q3 		– Sell
-57,945
Closed -$3.07M – 1767
2025
Q2 		$3.07M Buy
57,945
+44,380
+327% +$2.08M 0.03% 582
2025
Q1 		$673K Buy
+13,565
New +$754K 0.01% 1032
2024
Q4 		– Sell
-81,586
Closed -$4.01M – 1760
2024
Q3 		$4.01M Buy
81,586
+76,568
+1,526% +$3.59M 0.02% 498
2024
Q2 		$226K Sell
5,018
-27,099
-84% -$921K ﹤0.01% 1374
2024
Q1 		$2M Buy
+32,117
New +$2.08M 0.02% 702
2023
Q4 		– Sell
-25,330
Closed -$1.19M – 1751
2023
Q3 		$1.19M Sell
25,330
-27,470
-52% -$1.37M 0.01% 904
2023
Q2 		$2.34M Sell
52,800
-18,166
-26% -$645K 0.02% 744
2023
Q1 		$1.5M Buy
70,966
+40,734
+135% +$907K 0.01% 997
2022
Q4 		$601K Buy
30,232
+28,506
+1,652% +$1.42M 0.01% 1109
2022
Q3 		$85K Buy
+1,726
New +$81.5K ﹤0.01% 1761
2021
Q3 		– Sell
-543
Closed -$105K – 2373
2021
Q2 		$105K Sell
543
-1,439
-73% -$473K ﹤0.01% 2137
2021
Q1 		$806K Buy
+1,982
New +$884K 0.01% 1049

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Michael Gelband's IRON Position: Q2 2026 in Review

Michael Gelband opened a new position in Disc Medicine (IRON) in Q2 2026: 51,623 shares worth $3.78M. The stake represents 0.02% of the portfolio and ranks #592 among its holdings. This is a return to the name: Michael Gelband previously reported a position in IRON as recently as Q4 2025.

Michael Gelband first reported a position in IRON in Q1 2021 and has held it in 14 quarters since. The position peaked at $4.62M in Q4 2025. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Michael Gelband held 51,623 shares of Disc Medicine worth $3.78M as of Q2 2026.
  • Disc Medicine was a new Michael Gelband position in Q2 2026.
  • Disc Medicine made up 0.02% of Michael Gelband's portfolio in Q2 2026, its #592 holding.
  • Michael Gelband first reported a position in Disc Medicine in Q1 2021 and has held it in 14 quarters since.
  • Michael Gelband's Disc Medicine position peaked at $4.62M in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.